CEFTRIAVIS

This brand name is authorized in Nigeria.

Active ingredients

The drug CEFTRIAVIS contains one active pharmaceutical ingredient (API):

1	Ceftriaxone UNII 023Z5BR09K - CEFTRIAXONE SODIUM
	Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death.
	Read more about Ceftriaxone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-2856	Powder for injection	CEFTRIAVIS POWDER FOR INJECTION INJ_PWD 1000 mg 1 X 1 Vial	1 RNW-PP-103824 CEFTRIAVIS POWDER FOR INJECTION CEFTRIAXONE SODIUM USP 1000MG" CEFTRIAXONE SODIUM USP 1000MG" B4-2856 Drugs Imported Products 1x1vial Prescription Only Medicine (POM) 2/25/2020 NANDO PHARMACY LIMITED, OLD MARKET ROADONITSHA. ONITSHA ANAMBRA 8123491477 chimaokoro@yahoo.co.uk MAKCUR LABORATORIES LTD., 46/4-7 DEHGAM ROAD, ZAK VILLAGE, TAL-DEHGAM, DIST. GANDHINAGAR GUJARAT STATE, INDIA., India	06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD04	Ceftriaxone	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-2856